Literature DB >> 27162643

Permissive hypoxemia/conservative oxygenation strategy: Dr. Jekyll or Mr. Hyde?

Huai-Wu He1, Da-Wei Liu1.   

Abstract

Entities:  

Year:  2016        PMID： 27162643      PMCID： PMC4842825          DOI： 10.21037/jtd.2016.03.58

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

Review 1.  Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis.

Authors:  Veena Manja; Satyan Lakshminrusimha; Deborah J Cook
Journal:  JAMA Pediatr       Date:  2015-04       Impact factor: 16.193

Review 2.  Goal-directed therapy for severely hypoxic patients with acute respiratory distress syndrome: permissive hypoxemia.

Authors:  Mohamed Abdelsalam; Ira M Cheifetz
Journal:  Respir Care       Date:  2010-11       Impact factor: 2.258

3.  BTS guideline for emergency oxygen use in adult patients.

Authors:  B R O'Driscoll; L S Howard; A G Davison
Journal:  Thorax       Date:  2008-10       Impact factor: 9.139

4.  Pulmonary hypertension in severe acute respiratory failure.

Authors:  W M Zapol; M T Snider
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

5.  Atelectasis causes vascular leak and lethal right ventricular failure in uninjured rat lungs.

Authors:  Michelle Duggan; Conán L McCaul; Patrick J McNamara; Doreen Engelberts; Cameron Ackerley; Brian P Kavanagh
Journal:  Am J Respir Crit Care Med       Date:  2003-03-27       Impact factor: 21.405

6.  The association between hyperoxia and patient outcomes after cardiac arrest: analysis of a high-resolution database.

Authors:  Jonathan Elmer; Michael Scutella; Raghevesh Pullalarevu; Bo Wang; Nishit Vaghasia; Stephen Trzeciak; Bedda L Rosario-Rivera; Francis X Guyette; Jon C Rittenberger; Cameron Dezfulian
Journal:  Intensive Care Med       Date:  2014-12-04       Impact factor: 17.440

7.  Conservative versus Liberal Oxygenation Targets for Mechanically Ventilated Patients. A Pilot Multicenter Randomized Controlled Trial.

Authors:  Rakshit Panwar; Miranda Hardie; Rinaldo Bellomo; Loïc Barrot; Glenn M Eastwood; Paul J Young; Gilles Capellier; Peter W J Harrigan; Michael Bailey
Journal:  Am J Respir Crit Care Med       Date:  2016-01-01       Impact factor: 21.405

8.  High central venous-to-arterial CO2 difference/arterial-central venous O2 difference ratio is associated with poor lactate clearance in septic patients after resuscitation.

Authors:  Huai-wu He; Da-wei Liu; Yun Long; Xiao-ting Wang
Journal:  J Crit Care       Date:  2015-10-31       Impact factor: 3.425

9.  Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients.

Authors:  Evert de Jonge; Linda Peelen; Peter J Keijzers; Hans Joore; Dylan de Lange; Peter H J van der Voort; Robert J Bosman; Ruud A L de Waal; Ronald Wesselink; Nicolette F de Keizer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097

10.  Clinical classification of tissue perfusion based on the central venous oxygen saturation and the peripheral perfusion index.

Authors:  Huaiwu He; Yun Long; Dawei Liu; Xiaoting Wang; Xiang Zhou
Journal:  Crit Care       Date:  2015-09-14       Impact factor: 9.097
View more
  3 in total

1.  The unknowns about oxygen therapy in critically ill patients.

Authors:  Rakshit Panwar
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 2.  Relationship between hyperoxemia and ventilator associated pneumonia.

Authors:  Karim Jaffal; Sophie Six; Farid Zerimech; Saad Nseir
Journal:  Ann Transl Med       Date:  2017-11

3.  Protocol for a feasibility randomised controlled trial of targeted oxygen therapy in mechanically ventilated critically ill patients.

Authors:  Daniel S Martin; Chris Brew-Graves; Neil McCartan; Gavin Jell; Ingrid Potyka; Jia Stevens; Norman R Williams; Margaret McNeil; B Ronan O'Driscoll; Monty Mythen; Michael P W Grocott
Journal:  BMJ Open       Date:  2019-01-17       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.